Ketoconazole increases the AUC of aprepitant 5-fold. The manufacturer recommends caution when aprepitant is used with ketoconazole or other strong inhibitors of CYP3A4, such as itraconazole. Fosaprepitant, a prodrug of aprepitant, would be expected to interact similarly. The lowest dose of aprepitant may be appropriate. Counsel patients about adverse effects (e.g. hiccups, fatigue, constipation, headache).
(16)
This site is intended for general information only. The information provided on this site does not constitute medical advice and should not be relied upon. You should not act or refrain from acting on any legal or medical matter based on the content of this site.